MULTI-OMICS-DRIVEN HERBAL RESEARCH: INTEGRATING METABOLOMICS, GENOMICS, AND SYSTEMS BIOLOGY TO DECODE THERAPEUTIC MECHANISMS
DOI:
https://doi.org/10.29121/ijetmr.v13.i3.2026.1746Keywords:
Multi-Omics, Network Pharmacology, Systems Biology, Metabolomics, Transcriptomics, Herbal Medicine, PhytochemicalsAbstract
Herbal medicines from traditional medical systems function as valuable resources which contain diverse medicinal compounds that can treat multiple medical conditions. The complex multi-component system of these products hinders their ability to meet conventional drug testing standards which focus on single drug and single target methods thus delaying their acceptance as modern clinical treatment methods. Multi-omics technologies which include genomics and transcriptomics and proteomics and metabolomics and systems biology have created a new scientific approach in phytomedicine research. This review examines how multi-omics research methods reveal the complex medicinal functions which herbal bioactive compounds possess. The research shows that genomic and transcriptomic analysis methods enable scientists to understand how phytochemicals control blood sugar levels through their impact on host gene networks and biological processes. The research investigates how the plant metabolomic profile which identifies all its phytochemicals interacts with herbal treatment to show metabolic changes in the host organism. This article demonstrates how systems biology and network pharmacology combine different high-throughput datasets into a unified system. Research scientists create detailed compound-target-disease networks which enable them to visualize how botanical extracts produce combined effects through multiple biological pathways. The development of standardized bioinformatic pipelines and data integration algorithms and the establishment of valid methods to measure the natural biological variability of herbal preparations continue to present major difficulties. The path from multi-omics data collection to the development of practical drug discovery solutions stands as the most important challenge which must be overcome to update herbal medicine practices while creating new network-based treatment methods.
Downloads
References
Buriani, A., Garcia-Bermejo, M. L., Bosisio, E., Xu, Q., Li, H., Dong, X., ... Williamson, E. M. (2012). Omic Techniques in Systems Biology Approaches to traditional ChinEse Medicine Research: Present and future. Journal of Ethnopharmacology, 140(3), 535-544. https://doi.org/10.1016/j.jep.2012.01.055
Chen, S., Hao, H., Zhao, L., and Wang, G. (2014). Network Pharmacology-Based Drug Discovery and Target Prediction. Current Pharmaceutical Design, 20(15), 2530-2541.
Hao, H., Zheng, X., and Wang, G. (2014). Insights into Botanical Drug Discovery and Development. Nature Reviews Drug Discovery, 13(4), 317. https://doi.org/10.1038/nrd4319
Harvey, A. L., Edrada-Ebel, R., and Quinn, R. J. (2015). The Re-Emergence of Natural Products for Drug Discovery in the Genomics Era. Nature Reviews Drug Discovery, 14(2), 111-129. https://doi.org/10.1038/nrd4510
Hopkins, A. L. (2008). Network Pharmacology: The Next Paradigm in Drug Discovery. Nature Chemical Biology, 4(11), 682-690. https://doi.org/10.1038/nchembio.118
Kellogg, J. J., Kvalheim, O. M., and Cech, N. B. (2020). Developing and Validating Analytical Methods for Botanical Dietary Supplements. Journal of Natural Products, 83(2), 535-551.
Li, S., Zhang, B., and Zhang, N. (2011). Network Target for Screening Synergistic Drug Combinations with Application to Traditional Chinese Medicine. BMC Systems Biology, 5(1), 1-13. https://doi.org/10.1186/1752-0509-5-S1-S10
Nicholson, J. K., Lindon, J. C., and Holmes, E. (1999). 'Metabonomics': Understanding the Metabolic Responses of Living Systems to Pathophysiological Stimuli Via Multivariate Statistical Analysis of Biological NMR Spectroscopic data. Xenobiotica, 29(11), 1181-1189. https://doi.org/10.1080/004982599238047
Pelkonen, O., Xu, Q., and Fan, T. P. (2014). Why is Research on Herbal Medicine so Difficult? British Journal of Pharmacology, 171(19), 4323-4326.
Su, C. H., Lin, Y., and Wang, L. (2021). Multi-Omics Approaches to the Study of Traditional Medicine. Frontiers in Pharmacology, 12, Article 655443.
Ulrich-Merzenich, G., Panek, D., Zeitler, H., Wagner, H., and Vetter, H. (2009). New Perspectives for Synergy Research with the "omic"-technologies. Phytomedicine, 16(6-7), 495-508. https://doi.org/10.1016/j.phymed.2009.04.001
Wang, X., Wang, Z., Zheng, J., and Li, S. (2012). TCM Network Pharmacology: A new Trend Towards Combining Traditional Medicine with Modern Medicine. Evidence-Based Complementary and Alternative Medicine, 2012, Article 789047.
Wishart, D. S. (2016). Emerging Applications of Metabolomics in Drug Discovery and Precision Medicine. Nature Reviews Drug Discovery, 15(7), 473-484. https://doi.org/10.1038/nrd.2016.32
Yang, Y., Zhang, Z., Li, S., Ye, X., Li, X., and He, K. (2022). Synergy Between Traditional Medicine and Modern Bioinformatics: Network Pharmacology. Briefings in Bioinformatics, 23(1), Article bbab440.
Zhang, R., Zhu, X., Bai, H., and Ning, K. (2017). Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment. Frontiers in Pharmacology, 8, Article 123.
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Dr. Kishore Kumar Godisela, Dr. Parshaveni Balaraju

This work is licensed under a Creative Commons Attribution 4.0 International License.
License and Copyright Agreement
In submitting the manuscript to the journal, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere.
- That its release has been approved by all the author(s) and by the responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
Copyright
Authors who publish with International Journal of Engineering Technologies and Management Research agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
For More info, please visit CopyRight Section





















